202 related articles for article (PubMed ID: 9635507)
21. Mechanisms of anti-vesicular stomatitis virus activity of deazaneplanocin and its 3-brominated analogs.
Gibbons JS; Khadka S; Williams CG; Wang L; Schneller SW; Liu C; Tufariello JM; Basler CF
Antiviral Res; 2021 Jul; 191():105088. PubMed ID: 34019950
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of the prostanoid clavulone II against vesicular stomatitis virus.
Bader T; Yamada Y; Ankel H
Antiviral Res; 1991 Dec; 16(4):341-55. PubMed ID: 1663734
[TBL] [Abstract][Full Text] [Related]
23. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication.
Parker J; Ahrens PB; Ankel H
Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950
[TBL] [Abstract][Full Text] [Related]
24. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
Hoshino M; Taira H; Hattori S; Kawakita M
J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
[TBL] [Abstract][Full Text] [Related]
25. Vesiculopolins, a New Class of Anti-Vesiculoviral Compounds, Inhibit Transcription Initiation of Vesiculoviruses.
Ogino M; Fedorov Y; Adams DJ; Okada K; Ito N; Sugiyama M; Ogino T
Viruses; 2019 Sep; 11(9):. PubMed ID: 31540123
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor induces PC12 cell differentiation in the presence of the protein kinase inhibitor K-252a.
Isono F; Widmer HR; Hefti F; Knüsel B
J Neurochem; 1994 Oct; 63(4):1235-45. PubMed ID: 7523586
[TBL] [Abstract][Full Text] [Related]
27. K252a, KT5720, KT5926, and U98017 support paclitaxel (taxol)-dependent cells and synergize with paclitaxel.
Abraham I; Wolf CL; Sampson KE; Laborde AL; Shelly JA; Aristoff PA; Skulnick HI
Cancer Res; 1994 Nov; 54(22):5889-94. PubMed ID: 7954419
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis.
Pica F; De Marco A; De Cesare F; Santoro MG
Antiviral Res; 1993 Mar; 20(3):193-208. PubMed ID: 8385894
[TBL] [Abstract][Full Text] [Related]
29. Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.
White JR; Zembryki D; Hanna N; Mong S
Biochem Pharmacol; 1990 Aug; 40(3):447-56. PubMed ID: 1696482
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of vesicular stomatitis virus RNA synthesis by 2',3'-dideoxycytidine 5'-triphosphate.
Patton JT; Davis NL; Wertz GW
J Gen Virol; 1983 Mar; 64 Pt 3():743-8. PubMed ID: 6298355
[TBL] [Abstract][Full Text] [Related]
31. K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells.
Hashimoto S
J Cell Biol; 1988 Oct; 107(4):1531-9. PubMed ID: 2844830
[TBL] [Abstract][Full Text] [Related]
32. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
Romanutti C; Castilla V; Coto CE; Wachsman MB
Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
[TBL] [Abstract][Full Text] [Related]
33. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a.
Usui T; Yoshida M; Abe K; Osada H; Isono K; Beppu T
J Cell Biol; 1991 Dec; 115(5):1275-82. PubMed ID: 1955475
[TBL] [Abstract][Full Text] [Related]
34. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of KT6124, a novel derivative of protein kinase inhibitor K-252a, and its mechanism of action.
Akinaga S; Ashizawa T; Gomi K; Ohno H; Morimoto M; Murakata C; Okabe M
Cancer Chemother Pharmacol; 1992; 29(4):266-72. PubMed ID: 1537071
[TBL] [Abstract][Full Text] [Related]
36. Phosphoprotein NS of vesicular stomatitis virus: phosphorylated states and transcriptional activities of intracellular and virion forms.
Masters PS; Banerjee AK
Virology; 1986 Oct; 154(2):259-70. PubMed ID: 3020780
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the multiplication of vesicular stomatitis and Newcastle disease virus by 2-deoxy-d-glucose.
Scholtissek C; Rott R; Hau G; Kaluza G
J Virol; 1974 Jun; 13(6):1186-93. PubMed ID: 4364895
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells.
Lancz G; Whitaker-Dowling P; Marsh YV; Bradley G; Eppstein DA; Hackney JF; Hulick-Swardstrom B
Proc Soc Exp Biol Med; 1990 Mar; 193(3):190-6. PubMed ID: 2154755
[TBL] [Abstract][Full Text] [Related]
39. K-252a, a potent inhibitor of protein kinase C from microbial origin.
Kase H; Iwahashi K; Matsuda Y
J Antibiot (Tokyo); 1986 Aug; 39(8):1059-65. PubMed ID: 3759657
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of NS protein by vesicular stomatitis virus nucleocapsids: lack of effect during RNA synthesis and separation of kinase from L protein.
Massey DM; Deans N; Lenard J
J Virol; 1990 Jul; 64(7):3259-64. PubMed ID: 2161940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
